Non-Hodgkin's Lymphoma

Showing NaN - NaN of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin's Lymphoma Trial in United States (Zevalin (ibritumomab tiuxetan), Rituxan (rituximab))

Terminated
  • Non-Hodgkin's Lymphoma
  • Zevalin (ibritumomab tiuxetan)
  • Rituxan (rituximab)
  • Huntsville, Alabama
  • +66 more
Sep 8, 2006

Non-Hodgkin's Lymphoma Trial in United States (Xcellerated T Cells)

Unknown status
  • Non-Hodgkin's Lymphoma
  • Xcellerated T Cells
  • Greenbrae, California
  • +17 more
Jun 23, 2005